• Janssen Halts Clinical Development of Alzheimer’s Candidate Atabecestat Due to Liver Issues
  • Phase 2 Trial Testing Alkahest’s Investigational GRF6019 for Alzheimer’s Doses First Patient
  • Institute on Aging Awards $2.5M to Launch Collaborative Research Project
  • Failed Verubecestat Trial May Call into Question Beta-amyloid Theory in Alzheimer’s, Study Suggests
  • Phase 3 of Large-scale Alzheimer’s Disease Study Looking to Enroll Hundreds of Participants
  • FDA Clearance Supports Start of Phase 2 Trial of TNX-102 SL for Agitation in Alzheimer’s Patients
  • New Genetically Engineered Rat Model Can Aid Alzheimer’s Research, Study Says
  • Biogen and Ionis Expand Collaboration to Develop Therapy Candidates for Alzheimer’s, Other Neurological Diseases
  • Sleep Deprivation Leads to Accumulation of Protein Fragment Associated With Alzheimer’s
  • First Stem Cell Therapy for Alzheimer’s Disease Approved, Applied in Japan
  • Donation to Brown University Will Boost Research Into Brain Diseases
  • Blood Test for Toxic Amyloid May Detect Alzheimer’s 8 Years Before Symptoms, Study Says